Publicaciones en colaboración con investigadores/as de Creighton University (1)

2019

  1. Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

    The Lancet Oncology, Vol. 20, Núm. 6, pp. 862-876